Isolation of fragments corresponding to domains a b c of the tetanus toxin molecule and preparation of human anti tetanus monoclonal antibodies with high neutralizing activity for study of structure function of tetanus toxin
Matsuda, M.; Sugimoto, N.; Okabe, T.; Kamei, M.; Hashizume, S.
Abstracts of Papers American Chemical Society 200(1-2): AGFD 53
1990
ISSN/ISBN: 0065-7727
Accession: 032069282
PDF emailed within 1 workday: $29.90
Related References
Matsuda, M.; Kamei, M.; Sugimoto, N.; Ma, Y.; Hashizume, S. 1992: Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies European Journal of Epidemiology 8(1): 1-8Matsuda, M.; Takahashi, M.; Katahira, J.; Kamei, M.; Hashizume, S. 2001: Immunology of tetanus toxin, anti-tetanus, immunogenic toxin fragments and human monoclonal antibodies Toxicon 39(2-3): 130
Lukic, I.; Filipovic, A.; Inic-Kanada, A.; Marinkovic, E.; Miljkovic, R.; Stojanovic, M. 2018: Cooperative binding of anti-tetanus toxin monoclonal antibodies: Implications for designing an efficient biclonal preparation to prevent tetanus toxin intoxication Vaccine 36(26): 3764-3771
Johnston, L.; Mawas, F.; Tierney, R.; Qazi, O.; Fairweather, N.; Sesardic, D. 2009: Transcutaneous delivery of tetanus toxin Hc fragment induces superior tetanus toxin neutralizing antibody response compared to tetanus toxoid Human Vaccines 5(4): 230-236
Ziegler Heitbrock, H.W.L.; Reiter, C.; Trenkmann, J.; Fuetterer, A.; Riethmueller, G. 1985: Human monoclonal antibodies against tetanus toxin construction of a biclonal cocktail protecting mice against lethal doses of tetanus toxin Immunobiology 170(1-2): 114
Gustafsson, B.; Whitmore, E.; Tiru, M. 1993: Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C Hybridoma 12(6): 699-708
Lukić, I.; Marinković, E.; Filipović, A.; Krnjaja, O.; Kosanović, D.; Inić-Kanada, A.; Stojanović, M. 2015: Key protection factors against tetanus: Anti-tetanus toxin antibody affinity and its ability to prevent tetanus toxin - ganglioside interaction Toxicon: Official Journal of the International Society on Toxinology 103: 135-144
Matsuda, M.; Makinaga, G.; Hirai, T. 1983: Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule Biken Journal 26(4): 133-143
Boucher, P.; Sato, H.; Sato, Y.; Locht, C. 1994: Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein Infection and Immunity 62(2): 449-456
Ziegler-Heitbrock, H.W.; Reiter, C.; Trenkmann, J.; Fütterer, A.; Riethmüller, G. 1986: Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule Hybridoma 5(1): 21-31
Leonardi, G. 1981: The anticholinesterase activity of tetanus toxin: comparison between intoxication by organophosphoric esters and by tetanus toxin Annali Sclavo; Rivista di Microbiologia e di Immunologia 23(3): 290-300
Ledley, F.D.; Lee, G.; Kohn, L.D.; Habig, W.H.; Hardegree, M.C. 1977: Tetanus toxin interactions with thyroid plasma membranes. Implications for structure and function of tetanus toxin receptors and potential pathophysiological significance Journal of Biological Chemistry 252(12): 4049-4055
Marshall, J.D.; Schneider, N.; Smith, F.J. 1957: Studies of tetanus toxin and antitoxin in human sera. I. Production of high titer tetanus toxin for use in serologic tests Medical Technicians Bulletin 8(4): 143-148
Wellhoener, H.H.; Erdmann, G.; Hanauske, A. 1979: Inactivation of tetanus toxin inside the spinal cord by intra thecally injected anti tetanus fab' 2 fragments Naunyn-Schmiedeberg's Archives of Pharmacology 308(Suppl): R46
Erdmann, G.; Hanauske, A.; Wellhoner, H.H. 1981: Intraspinal distribution and reaction in the grey matter with tetanus toxin of intracisternally injected anti-tetanus toxoid F (ab)2 fragments Brain Research 211(2): 367-377
Kamei, M.; Hashizume, S.; Sugimoto, N.; Ozutsumi, K.; Matsuda, M. 1990: Stable mouse human human hybridomas producing high tetanus toxin neutralizing human monoclonal antibodies suitable for large scale production Murakami, H (Ed ) Trends in Animal Cell Culture Technology; Second Annual Meeting Of The Japanese Association For Animal Cell Technology, Tsukuba, Japan, November 20-22, 1989 Xiv+342p Kodansha Ltd : Tokyo, Japan; Vch Verlagsgesellschaft Mbh: Weinheim, Germany; Vch Publishers, Inc : New York, New York, Usa Illus 173-176
Volk, W.A.; Bizzini, B.; Snyder, R.M.; Bernhard, E.; Wagner, R.R. 1984: Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule Infection and Immunity 45(3): 604-609
Helting, T.B.; Zwisler, O. 1977: Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments Journal of Biological Chemistry 252(1): 187-193
Kenrick, K.G.; Wallace, R.C.; Ismay, S.L. 1990: An improved assay for human tetanus anti-toxin and its use in the accession of human plasma for the production of high-titre tetanus immunoglobulin Vox Sanguinis 58(1): 35-39
Stein, S.; Weiss, A.; Adermann, K.; Lazarovici, P.; Hochman, J.; Wellhöner, H. 1999: A disulfide conjugate between anti-tetanus antibodies and HIV (37-72)Tat neutralizes tetanus toxin inside chromaffin cells FEBS Letters 458(3): 383-386